Evidence map›Paper›PMID 39856193›Full record

ArticleScientific reports2025

Attention-based interactive multi-level feature fusion for named entity recognition.

Yiwu Xu, Yun Chen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yiwu XuGuangzhou Institute of Science and Technology, Guangzhou, 510540, China.
Yun ChenNanfang College Guangzhou, Guangzhou, 510970, China. 1210437650@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Named Entity Recognition (NER) is an essential component of numerous Natural Language Processing (NLP) systems, with the aim of identifying and classifying entities that have specific meanings in raw text, such as person (PER), location (LOC), and organization (ORG). Recently, Deep Neural Networks (DNNs) have been extensively applied to NER tasks owing to the rapid development of deep learning technology. However, despite their advancements, these models fail to take full advantage of the multi-level features (e.g., lexical phrases, keywords, capitalization, suffixes, etc.) of entities and the dependencies between different features. To address this issue, we propose a novel attention-based interactive multi-level feature fusion (AIMFF) framework, which aims to improve NER by obtaining multi-level features from different perspectives and interactively capturing the dependencies between different features. Our model is composed of four parts: the input, feature extraction, feature fusion, and sequence-labeling layers. First, we generate the original word- and character-level embeddings in the input layer. Then, we incorporate four parallel components to capture global word-level, local word-level, global character-level, and local character-level features in the feature extraction layer to enrich word embeddings with comprehensive multi-level semantic features. Next, we adopt cross-attention in the feature fusion layer to fuse features by exploiting the interaction between word- and character-level features. Finally, the fused features are fed into the sequence labeling layer to predict the word labels. We conducted generous comparative experiments on three datasets, and the experimental results showed that our model achieved better performance than several state-of-the-art models.

Indexed as

Cross-attentionFeature fusionMulti-level featuresNamed entity recognition

Identifiers

PMID39856193
PMCPMC11760954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.